← Back to Clinical Trials
Recruiting NCT06290427

NCT06290427 Comparison of Outcomes of Multiple Platforms for Assisted Robotic-Kidney (COMPAR-K)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06290427
Status Recruiting
Phase
Sponsor Azienda Ospedaliera Universitaria Integrata Verona
Condition Renal Carcinoma
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2024-02-01
Primary Completion 2024-12-12

Trial Parameters

Condition Renal Carcinoma
Sponsor Azienda Ospedaliera Universitaria Integrata Verona
Study Type INTERVENTIONAL
Phase N/A
Enrollment 30
Sex ALL
Min Age 18 Years
Max Age 90 Years
Start Date 2024-02-01
Completion 2024-12-12
Interventions
DaVinci RAPNHugo RAS RAPN

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The Urology Unit of AOUI Verona proposes a clinical study aimed at a preliminary evaluation of postoperative complications specifically focused on robotic partial nephrectomy (RAPN) procedures using two currently available platforms: * DaVinci®; * Hugo®. The questions it aims to answer are: Does the estimation of the post-operative complications suggest something? Are differences (intra- and post-operative, oncological, functional, technical, and economic) among the three intervention approaches observable? Participants will be invited to join one of these two experimental group: 1. surgery with the DaVinci platform; 2. surgery with the Hugo platform.

Eligibility Criteria

Inclusion Criteria: * patient aged between 18 and 90 years old; * patient with localized kidney tumor suitable for partial nephrectomy; * patient able to understand and sign the informed consent; * patient compliance with the follow-up program. Exclusion Criteria: * patient who do not fall within the inclusion age range; * patient not suitable for partial nephrectomy; * patient unable to understand and sign the informed consent; * patient unable to follow the monitoring program; * patient refusal to participate to the study.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology